Darren Beckett Appointed Chief Technology Officer at Velo3D
January 30, 2025 - 11:04
Velo3D has announced the appointment of Darren Beckett as its new Chief Technology Officer. With over 25 years of experience in hardware and software development, Beckett brings a wealth of knowledge to the additive manufacturing (AM) and semiconductor industries. His extensive background positions him as a valuable asset in driving innovation and advancing Velo3D's technological capabilities.
Throughout his career, Beckett has demonstrated a strong commitment to developing cutting-edge solutions that enhance operational efficiency and product quality. His previous roles have equipped him with the expertise needed to navigate the complexities of both AM and semiconductor technologies, making him well-suited to lead Velo3D's technological initiatives.
As Velo3D continues to expand its influence in the additive manufacturing sector, Beckett's leadership is expected to play a crucial role in shaping the company's future. His strategic vision and technical acumen will be instrumental in fostering advancements that align with the evolving needs of the industry.
MORE NEWS
July 1, 2025 - 12:35
Westville Library Receives Grant for Technology and Internet EnhancementsWESTVILLE — In an era where technology is rapidly transforming our daily lives, the Westville Public Library in Vermilion County is taking significant steps to modernize its services. The library...
June 30, 2025 - 22:18
Webstar Technology Group Secures Contract for "The Forge" Project in Downtown AtlantaWebstar Technology Group, a prominent player in real estate development and digital asset innovation, has officially placed its transformative project, `The Forge,` under contract in the heart of...
June 30, 2025 - 04:30
Voice-Based Risk Assessment Firm Secures $60 Million in Series D FundingClearspeed, a prominent player in the voice-based risk assessment technology sector, has successfully raised $60 million in its Series D funding round. This latest investment elevates the company`s...
June 29, 2025 - 04:10
First Patient Enrolled in Groundbreaking Study on MicroPulse Technology for DMEA significant milestone has been reached in a clinical study evaluating the effectiveness of MicroPulse technology as an adjunct to anti-VEGF therapy for patients suffering from diabetic macular...